DrugPatentWatch Database Preview
MACRILEN Drug Profile
When do Macrilen patents expire, and when can generic versions of Macrilen launch?
Macrilen is a drug marketed by Strongbridge Ireland and is included in one NDA. There are two patents protecting this drug.
This drug has seventy-two patent family members in thirty-one countries.
The generic ingredient in MACRILEN is macimorelin acetate. One supplier is listed for this compound. Additional details are available on the macimorelin acetate profile page.
Summary for MACRILEN
International Patents: | 72 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Suppliers / Packagers: | 1 |
Bulk Api Vendors: | 7 |
Patent Applications: | 19 |
Drug Prices: | Drug price information for MACRILEN |
DailyMed Link: | MACRILEN at DailyMed |

Generic Entry Opportunity Date for MACRILEN
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for MACRILEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Strongbridge Ireland | MACRILEN | macimorelin acetate | FOR SOLUTION;ORAL | 205598-001 | Dec 20, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
Strongbridge Ireland | MACRILEN | macimorelin acetate | FOR SOLUTION;ORAL | 205598-001 | Dec 20, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
Strongbridge Ireland | MACRILEN | macimorelin acetate | FOR SOLUTION;ORAL | 205598-001 | Dec 20, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
Strongbridge Ireland | MACRILEN | macimorelin acetate | FOR SOLUTION;ORAL | 205598-001 | Dec 20, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for MACRILEN
Country | Document Number | Estimated Expiration |
---|---|---|
Norway | 20025893 | ➤ Sign Up |
Spain | 2288724 | ➤ Sign Up |
Hong Kong | 1056555 | ➤ Sign Up |
Portugal | 1344773 | ➤ Sign Up |
China | 1431998 | ➤ Sign Up |
Denmark | 1524272 | ➤ Sign Up |
World Intellectual Property Organization (WIPO) | 0196300 | ➤ Sign Up |
Country | Document Number | Estimated Expiration |